Valneva begins COVID-19 vaccine regulatory review process in UK
Valneva today commenced rolling submission for initial approval of its COVID-19 vaccine candidate, VLA2001, with the UK health regulator.
Archives for August 23, 2021
Pfizer to acquire immuno-oncology company Trillium
Pfizer will acquire Trillium Therapeutics Inc.; strengthening its work in oncology with the addition of next-generation, investigational immuno-therapeutics for hematological malignancies.